Pharmosa Biopharm Inc. is a biotechnology company focusing on developing a new drug by exploiting our proprietary formulation and manufacturing technology. The main products of company include the development of drug-device combination product through 505(b)2 or hybrid regulatory pathway, applying our proprietary liposome technology to create the innovative nanoparticle formulation with existing drug. The company was established in 2000 and is headquartered in Taipei City, Taiwan.
Headquarters
3F.-3, No. 66, Sanchong Rd, Nangang Dist
Taipei City; Taipei City;
Contact Details: Purchase the Pharmosa Biopharm Inc. report to view the information.
Website: http://www.pharmosa.com.tw
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service